Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer.


Journal

Journal of the National Cancer Institute
ISSN: 1460-2105
Titre abrégé: J Natl Cancer Inst
Pays: United States
ID NLM: 7503089

Informations de publication

Date de publication:
04 05 2021
Historique:
received: 01 05 2020
revised: 12 08 2020
accepted: 07 10 2020
pubmed: 3 11 2020
medline: 25 2 2022
entrez: 2 11 2020
Statut: ppublish

Résumé

The role of poor diet quality in the rising incidence of colorectal cancer (CRC) diagnosed younger than age 50 years has not been explored. Based on molecular features of early-onset CRC, early-onset adenomas are emerging surrogate endpoints. In a prospective cohort study (Nurses' Health Study II), we evaluated 2 empirical dietary patterns (Western and prudent) and 3 recommendation-based indexes (Dietary Approaches to Stop Hypertension [DASH], Alternative Mediterranean Diet [AMED], and Alternative Healthy Eating Index [AHEI]-2010) with risk of early-onset adenoma overall and by malignant potential (high-risk: ≥1 cm, tubulovillous or villous histology, high-grade dysplasia, or ≥3 adenomas), among 29 474 women with 1 or more lower endoscopy before age 50 years (1991-2011). Multivariable logistic regressions were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). We documented 1157 early-onset adenomas with 375 at high risk. Western diet was positively associated, whereas prudent diet, DASH, AMED, and AHEI-2010 were inversely associated with risk of early-onset adenoma. The associations were largely confined to high-risk adenomas (the highest vs lowest quintile: Western, OR = 1.67, 95% CI = 1.18 to 2.37; prudent, OR = 0.69, 95% CI = 0.48 to 0.98; DASH, OR = 0.65, 95% CI = 0.45 to 0.93; AMED, OR = 0.55, 95% CI = 0.38 to 0.79; AHEI-2010, OR = 0.71, 95% CI = 0.51 to 1.01; all Ptrend ≤ .03), driven by those identified in the distal colon and rectum (all Ptrend ≤ .04, except AMED: Ptrend = .14). Poor diet quality was associated with an increased risk of early-onset distal and rectal adenomas of high malignant potential. These findings provide preliminary but strong support to the role of diet in early-onset CRC.

Sections du résumé

BACKGROUND
The role of poor diet quality in the rising incidence of colorectal cancer (CRC) diagnosed younger than age 50 years has not been explored. Based on molecular features of early-onset CRC, early-onset adenomas are emerging surrogate endpoints.
METHODS
In a prospective cohort study (Nurses' Health Study II), we evaluated 2 empirical dietary patterns (Western and prudent) and 3 recommendation-based indexes (Dietary Approaches to Stop Hypertension [DASH], Alternative Mediterranean Diet [AMED], and Alternative Healthy Eating Index [AHEI]-2010) with risk of early-onset adenoma overall and by malignant potential (high-risk: ≥1 cm, tubulovillous or villous histology, high-grade dysplasia, or ≥3 adenomas), among 29 474 women with 1 or more lower endoscopy before age 50 years (1991-2011). Multivariable logistic regressions were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS
We documented 1157 early-onset adenomas with 375 at high risk. Western diet was positively associated, whereas prudent diet, DASH, AMED, and AHEI-2010 were inversely associated with risk of early-onset adenoma. The associations were largely confined to high-risk adenomas (the highest vs lowest quintile: Western, OR = 1.67, 95% CI = 1.18 to 2.37; prudent, OR = 0.69, 95% CI = 0.48 to 0.98; DASH, OR = 0.65, 95% CI = 0.45 to 0.93; AMED, OR = 0.55, 95% CI = 0.38 to 0.79; AHEI-2010, OR = 0.71, 95% CI = 0.51 to 1.01; all Ptrend ≤ .03), driven by those identified in the distal colon and rectum (all Ptrend ≤ .04, except AMED: Ptrend = .14).
CONCLUSION
Poor diet quality was associated with an increased risk of early-onset distal and rectal adenomas of high malignant potential. These findings provide preliminary but strong support to the role of diet in early-onset CRC.

Identifiants

pubmed: 33136160
pii: 5951179
doi: 10.1093/jnci/djaa164
pmc: PMC8096368
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

543-552

Subventions

Organisme : NCI NIH HHS
ID : U01 CA176726
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK125838
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA186107
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA253185
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA222940
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Int J Cancer. 2002 Oct 10;101(5):403-8
pubmed: 12216066
Am J Epidemiol. 2017 Apr 1;185(7):570-584
pubmed: 28338828
Histopathology. 2007 Jan;50(1):113-30
pubmed: 17204026
Nat Rev Gastroenterol Hepatol. 2019 Dec;16(12):713-732
pubmed: 31455888
Obes Rev. 2015 Jul;16(7):607-19
pubmed: 25925734
Cancer Prev Res (Phila). 2011 Oct;4(10):1710-8
pubmed: 21881026
Nat Commun. 2015 Mar 11;6:6528
pubmed: 25758642
Arch Intern Med. 2003 Feb 10;163(3):309-14
pubmed: 12578511
JAMA Intern Med. 2014 Oct;174(10):1587-95
pubmed: 25179639
Gastroenterology. 2010 Jun;138(6):2029-2043.e10
pubmed: 20420944
Nat Rev Cancer. 2003 Aug;3(8):601-14
pubmed: 12894248
J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 28376186
Ann N Y Acad Sci. 2017 Apr;1393(1):21-33
pubmed: 28436102
Am J Clin Nutr. 2018 Nov 1;108(5):1092-1103
pubmed: 30289433
Arch Intern Med. 2008 Apr 14;168(7):713-20
pubmed: 18413553
Int J Cancer. 2016 Nov 15;139(10):2232-42
pubmed: 27466215
JAMA. 2008 Dec 17;300(23):2765-78
pubmed: 19088354
J Nutr. 2012 Jun;142(6):1009-18
pubmed: 22513989
Am J Clin Nutr. 2012 Mar;95(3):580-6
pubmed: 22301926
JNCI Cancer Spectr. 2018 Nov;2(4):pky073
pubmed: 30740587
Br J Sports Med. 2018 Jul;52(13):826-833
pubmed: 29146752
N Engl J Med. 2002 Jun 6;346(23):1781-5
pubmed: 12050337
JAMA Oncol. 2018 Mar 1;4(3):366-373
pubmed: 29346484
Cancer. 2020 Mar 15;126(6):1351-1353
pubmed: 31850529
Am J Clin Nutr. 1999 Feb;69(2):243-9
pubmed: 9989687
J Nutr. 2006 Feb;136(2):466-72
pubmed: 16424129
Int J Cancer. 2010 Apr 15;126(8):1997-2001
pubmed: 19795420
Int J Epidemiol. 2020 Feb 1;49(1):259-269
pubmed: 31038671
Clin Gastroenterol Hepatol. 2019 Dec;17(13):2657-2667.e9
pubmed: 31525516
Gastroenterology. 2012 Sep;143(3):844-857
pubmed: 22763141
Eur J Cancer Prev. 2017 May;26(3):201-211
pubmed: 26945285
N Engl J Med. 2016 Mar 17;374(11):1065-75
pubmed: 26981936
Cancer Causes Control. 2013 Feb;24(2):335-41
pubmed: 23224326
CA Cancer J Clin. 2017 May 6;67(3):177-193
pubmed: 28248415
Nutr Rev. 2010 Jul;68(7):389-408
pubmed: 20591107
Curr Opin Lipidol. 2002 Feb;13(1):3-9
pubmed: 11790957
Gastroenterology. 2008 May;134(5):1311-5
pubmed: 18471508
Gastroenterology. 2015 May;148(6):1244-60.e16
pubmed: 25575572
J Clin Oncol. 2009 Sep 20;27(27):4542-7
pubmed: 19704062
Eur J Cancer Prev. 2012 Jan;21(1):15-23
pubmed: 21946864
Gastroenterology. 2014 Feb;146(2):357-373
pubmed: 24315827
Gut. 2018 Apr;67(4):672-678
pubmed: 28377387
Int J Cancer. 2015 May 15;136(10):2388-401
pubmed: 25335850
Eur J Nutr. 2018 Aug;57(5):1701-1720
pubmed: 29080978
Nat Rev Microbiol. 2014 Oct;12(10):661-72
pubmed: 25198138
Gastroenterology. 2017 Jun;152(8):1944-1953.e1
pubmed: 28249812
Cancer. 2019 Jun 15;125(12):2002-2010
pubmed: 30854646
Gut. 2020 May;69(5):970-972
pubmed: 31209182
World J Gastroenterol. 2016 Feb 7;22(5):1736-44
pubmed: 26855533
Nat Rev Gastroenterol Hepatol. 2016 Dec;13(12):691-706
pubmed: 27848961
JAMA Oncol. 2019 Jan 1;5(1):37-44
pubmed: 30326010
Cancer Causes Control. 2004 Nov;15(9):853-62
pubmed: 15577287
Dig Liver Dis. 2018 Jun;50(6):521-532
pubmed: 29615301
Gastroenterology. 2017 Aug;153(2):386-394.e2
pubmed: 28428143
Am J Epidemiol. 1992 May 15;135(10):1114-26; discussion 1127-36
pubmed: 1632423
Gastroenterology. 2017 Jul;153(1):307-323
pubmed: 28600072
Clin Gastroenterol Hepatol. 2021 Apr;19(4):680-689.e12
pubmed: 32428708
JAMA. 2020 Mar 24;323(12):1161-1174
pubmed: 32207798
CA Cancer J Clin. 2020 May;70(3):145-164
pubmed: 32133645
J Am Coll Nutr. 2015;34(6):521-43
pubmed: 25941850
Gastroenterology. 2010 Jun;138(6):2088-100
pubmed: 20420948
JAMA Oncol. 2016 Jun 1;2(6):762-9
pubmed: 26940135
Asian Pac J Cancer Prev. 2015;16(17):7967-73
pubmed: 26625827
Gastroenterology. 2018 Aug;155(2):355-373.e18
pubmed: 29702117
J Natl Cancer Inst. 2005 Nov 16;97(22):1679-87
pubmed: 16288121
JAMA. 2015 Mar 17;313(11):1133-42
pubmed: 25781442

Auteurs

Xiaobin Zheng (X)

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Department of Colorectal Surgery, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China.
Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China.

Jinhee Hur (J)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Long H Nguyen (LH)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Jie Liu (J)

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Brown School, Washington University in St. Louis, St. Louis, MO, USA.

Mingyang Song (M)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Kana Wu (K)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Stephanie A Smith-Warner (SA)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Shuji Ogino (S)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.

Walter C Willett (WC)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Andrew T Chan (AT)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Edward Giovannucci (E)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Yin Cao (Y)

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH